Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Trump Admin Releases Final Rule Attacking Healthcare for Low-Income Trans Kids

Since President Donald Trump returned to the White House, he’s been vowing to stamp out gender-affirming medical care—what his administration terms “sex-rejecting procedures”—for young people diagnosed with gender dysphoria. Now, his administration is specifically going after the health care of trans kids from low-income families. On Tuesday, the Centers for Medicare & Medicaid Services released…

We haven't written up this one. Mother Jones has the full story — the link below goes straight to it.

Read the original at motherjones.com →

More in Health & Medicine

Celltrion Expands Market Presence in Spain and Portugal Through Tender Wins

Celltrion is rapidly strengthening its presence in Spain and Portugal, securing a series of government and regional tenders while expanding sales and marketing activities to drive prescriptions and…

  • Celltrion wins government tenders in Spain and Portugal, expanding market presence.
  • Omlyclo biosimilar dominates Spanish market with 90% share by June.
  • Actemra and other biosimilars gain significant market share in Spain and Portugal.

JW Pharmaceutical’s Gout Drug Candidate Outperforms Febuxostat in Phase 3 Trial

JW Pharmaceutical has reported positive results from a multinational Phase 3 trial of its gout drug candidate epaminurad (code name URC102), with the 6mg dose demonstrating statistically superior…

  • JW Pharmaceutical's epaminurad (URC102) outperformed febuxostat in Phase 3 gout trial.
  • Epaminurad achieved 50.0% serum uric acid reduction vs. 38.3% for febuxostat 40mg.
  • Safety profiles were comparable with no drug-related deaths reported.

More from Wednesday 12 August →